T. Eing-Mei

No ORCID on file · 1 paper in corpus

article 2026

L26/P-340 Comparative risks of dienogest versus medroxyprogesterone acetate in women with endometriosis and adenomyosis: a nationwide population-based cohort study

·doi:10.1093/humrep/deag083.676

Abstract Study question To compare the risk of dienogest (DNG) with medroxyprogesterone acetate (MPA) for treating endometriosis and adenomyosis. Summary answer DNG demonstrates a significantly protective effect against gynecologic and horm…